|
Table 2
|
Control group
|
CKD Stages I-V
|
p
|
|---|
|
N=24
|
N=80
|
|---|
|
E/A
|
0.8 (0.65-1.1)
|
0.9 (0.8-1.2)
|
NS
|
|
E/E’
|
7.5±2.1
|
9.9±4.7
|
NS
|
|
Hypertrophy [%]
|
52
|
95.3
|
NS
|
|
Diastolic dysfunction [%]
|
29
|
93.2
|
NS
|
|
Contractility dysfunction [%]
|
57.1
|
52.8
|
NS
|
|
Stenosis
|
0
|
3.2
|
NS
|
|
Mitral valve fibrosis
|
53.3
|
81.3
|
P<0.01
|
|
Aortic valve fibrosis
|
0
|
14.1
|
NS
|
|
Mitral valve calcification
|
13.3
|
14.1
|
NS
|
|
Aortic valve calcification
|
0
|
30.2
|
P<0.02
|
|
IM
|
46.7
|
63.1
|
NS
|
|
IA
|
0
|
6.7
|
NS
|
|
IT
|
16.7
|
43.8
|
NS
|
- Abbreviations used in Table 1: IM mitral insufficiency, IA atrial insufficiency, IT tricuspid insufficiency, NS not significant
